Clostridium perfringens infection complicating chemotherapy for choriocarcinoma. | Canada Hyperbarics Skip to main content
Review Obstetrics and gynecology 1976

Clostridium perfringens infection complicating chemotherapy for choriocarcinoma.

Lacey CG, Futoran R, Morrow CP — Obstetrics and gynecology, 1976

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported a case of Clostridium perfringens sepsis and gas gangrene complicating chemotherapy for gestational choriocarcinoma.

What They Found

They found that this single case of infection was successfully eradicated using a combination of antibiotics, surgery, and hyperbaric oxygen therapy. The study also reviewed the pathophysiology, diagnosis, and treatment of this unusual but often lethal complication.

What This Means for Canadian Patients

Canadian patients undergoing chemotherapy for choriocarcinoma should be aware of the rare but serious risk of Clostridium perfringens infection. Prompt diagnosis and a multi-modal treatment approach involving antibiotics, surgery, and hyperbaric oxygen can be life-saving.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

A significant limitation of this report is its reliance on a single case, which limits the generalizability of the findings.

Was this summary helpful?

Study Details

Study Type Review
Category Infection
Source Pubmed
PubMed ID 943077
Year Published 1976
Journal Obstetrics and gynecology
MeSH Terms Anti-Bacterial Agents; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Female; Gas Gangrene; Humans; Hyperbaric Oxygenation; Methotrexate; Pregnancy

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.